Histamine release from human buffy coat-derived mast cells

Area of Science:

• Immunology
• Cell Biology
• Allergy Research

Background:

• Mast cells are crucial in allergic inflammation, but human mast cell research is limited by a lack of accessible cell sources.
• Culturing human mast cells from CD34(+) progenitors provides a valuable alternative for scientific study.
• Human buffy coat preparations are identified as an abundant source for progenitor isolation.

Purpose of the Study:

• To characterize mast cells cultured from human buffy coat progenitors.
• To investigate the functional responses of these cultured mast cells to secretagogues and stabilizers.
• To compare the efficacy of anti-asthmatic agents on mediator release from these cells.

Main Methods:

• Human CD34(+) progenitors were isolated from buffy coats and cultured for mast cell differentiation.
• Cells were sensitized with human IgE and stimulated with anti-IgE, calcium ionophores, compound 48/80, and substance P.
• The effects of beta(2)-adrenoceptor agonists, phosphodiesterase inhibitors, cromolyn, and nedocromil on mediator release were assessed.

Main Results:

• Cultured mast cells released histamine dose-dependently upon activation by anti-IgE and calcium ionophores.
• Compound 48/80 and substance P were less effective secretagogues.
• Beta(2)-adrenoceptor agonists and phosphodiesterase inhibitors inhibited mediator release, while cromolyn and nedocromil did not.

Conclusions:

• Mast cells cultured from human buffy coat progenitors exhibit functional characteristics similar to the MC(T) subtype.
• These cells serve as a reliable model for investigating human mast cell biology and evaluating anti-asthmatic therapies.